Serenace 5mg / 1ml. 20mg / 2ml Injection
PDF Leaflet Revision Date: 17 February 2006
Clinical Summary
Quick overview from the medicine insert
Indication
Acute and chronic schizophrenia, mania, organic psychoses, agitation, childhood behavioral disorders.
Dosage (summary)
Adults: 2-10 mg IM for acute conditions; max 30 mg IM for emergencies.
Special Populations
- Elderly
- Debilitated patients
- Children
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Anticoagulants
- Carbamazepine
- Lithium
- CNS depressants
- Metoclopramide
Contraindications
- Parkinson's disease
- CNS depression
- Hypersensitivity
- Bone-marrow suppression
- Phaeochromocytoma
Common side effects
- Extrapyramidal symptoms
- Hypotension
- Neurological effects
- Insomnia
- Agitation
Counselling Points
- Avoid hazardous tasks initially
- Monitor for signs of dystonia
- Regular eye exams recommended
- Avoid abrupt withdrawal
Serious warnings
- Severe dystonic reactions
- Tardive dyskinesia
- Neuroleptic malignant syndrome
- Risk of sudden death
Important Disclaimer
The Serenace 5mg / 1ml. 20mg / 2ml Injection professional information leaflet below is the property of Pfizer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
